Drug Trial Radar · NCT00477451
Staccato Alprazolam in Panic Attack
Last checked: Nov 20, 2026Latest source record: Jun 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
49
Actual
Start
May 2007
Primary completion
Apr 2008
Study completion Apr 2008
Sponsor
- Lead sponsor
- Alexza Pharmaceuticals, Inc.Not stated
- Sponsor type
- Not stated
- First posted
- May 23, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We are developing Staccato™ Alprazolam for the treatment of Panic attacks associated with panic disorder. This study will provide an initial assessment of efficacy, and to continue to describe the tolerability and pharmacokinetics, of a single inhaled dose of Staccato Alprazolam on a doxapram-induced panic attack in patients with panic disorder.
Conditions
- Treatment of Induced Panic Attack
Interventions
Inhaled placeboDrug
Inhaled Staccato Alprazolam Placebo
Inhaled alprazolam 1 mgDrug
Inhaled Staccato Alprazolam 1 mg
Inhaled alprazolam 2 mgDrug
Inhaled Staccato Alprazolam 2 mg
IV doxapramDrug
0.5 mg/kg doxapram IV approximately 10s after receiving inhaled alprazolam or placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Doxapram-induced Panic AttackTime frame: 0 to 2 hours
- Duration of the Doxapram-induced Panic AttackTime frame: 1 hr post-dose
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
SUNY Downstate Medical Center
Brooklyn, New York
New York State Psychiatric Institute
New York, New York
Mt. Sinai School Of Medicine
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.